DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Friedman CF, Clark V, Raikhel AV. et al.
Thinking critically about classifying adverse events: incidence of pancreatitis in patients treated with nivolumab + ipilimumab.
J Natl Cancer Inst 2016;
109 (04) 109
We do not assume any responsibility for the contents of the web pages of other providers.